Novo Nordisk A/S ranks in the top quartile of its peer group, with stability as the main structural constraint. Trend conditions have deteriorated, without yet reaching an extreme downside state. Price action is not yet fully confirming the underlying structural profile.
Peer-relative scores, weakest to strongest
Novo Nordisk A/S develops pharmaceutical products with a focus on diabetes and weight-loss therapies. The company is a leading player in the GLP-1 treatment segment.
Novo Nordisk is priced as a structural GLP-1 winner, with the market attaching a premium that reflects heightened sensitivity to any sign of volatility—1Y volatility stands at 38.5%, well above the pharma peer median. Each quarter is interpreted as confirmation of leadership, as the company delivers a sector-leading 44.7% operating margin with its GLP-1 portfolio. This focus on GLP-1 therapies, supported by a strong brand and global scale, reduces peer-relative weaknesses in the share price. The market prices in ongoing dominance and discounts peer risks. A break in the GLP-1 narrative or a major competitive move would likely trigger sharp repricing.
Break down NOVO-B.CO's position across all dimensions with the full interactive tool.
This analysis is rule-based and descriptive. Peer-relative scores are derived from functional peer group comparisons using publicly available financial data. Scores reflect structural positioning only and do not constitute investment advice, a buy or sell recommendation, or a forecast of future performance. AssetNext peer scores are recalculated periodically as new data becomes available.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.